Xcout Intel
KSQ Therapeutics, Inc.
KSQ Therapeutics, Inc. is a pharmaceutical manufacturing and biotechnology company located in Lexington, Massachusetts. The company focuses on drug discovery and development through its proprietary screening platform.
Subscribe to see KSQ Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
KSQ Therapeutics, Inc. at a glance
KSQ Therapeutics, Inc. is a biotechnology company headquartered in United States. Its most recent funding round, Series C, raised $80.6M in September 2018. Xcout tracks 9 named people at KSQ Therapeutics, Inc., including Qasim Rizvi (Chief Executive Officer).
KSQ Therapeutics, Inc. leadership
- Qasim RizviChief Executive Officer
- Chris HeberligChief Financial Officer
- Thomas LeitchChief Technology Officer
- Anna Truppel-HartmannChief Medical Officer
- Lance OstromChief Business Officer
- Micah BensonChief Scientific Officer
3 more named people on record for KSQ Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
KSQ Therapeutics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $80.6M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Get KSQ Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on KSQ Therapeutics, Inc. in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access